GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT231212Recalls & reported problems
W. L. Gore & Associates, Inc. · EXCLUDER CONFORM AAA TRNK ENDO 23mmX12mmX12cm 15Fr · Class 3 · Implant
All models of GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral (10)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00733132651009), received between Jan 17, 2023 and Aug 15, 2025 — classified as 3 injuries.
The most frequently reported specific device problem is “Obstruction of Flow” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Obstruction of Flow1
- Partial Blockage1
- Patient-Device Incompatibility1
Patient problems
- Thrombosis/Thrombus2
- Inflammation1
- Obstruction/Occlusion1
- Pain1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryAug 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2021, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESES (CEXC). THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2025, THE PATIENT UNDERWENT REINTERVENTION TO TREAT A THROMBOSED LEFT LIMB OF THE CEXC DEVICE. THE PHYSICIAN CHOSE TO MAKE THE CEXC INTO AN AORTO-UNI-ILIAC (AUI) BY PLACING A GORE® EXCLUDER® CONTRALATERAL LEG COMPONENT (PLC231200) INVERTED WITH THE 23MM END AT THE RENAL ARTERIES WITH THE 16MM DIAMETER DISTAL END IN THE RIGHT LIMB. THE PHYSICIAN THEN DID A FEM-FEM BYPASS TO PROVIDE FLOW FROM THE RIGHT COMMON FEMORAL TO THE LEFT COMMON FEMORAL. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Thrombosis/Thrombus
MAUDE report 22822307 ↗InjuryMar 4, 2024Obstruction of Flow; Patient-Device Incompatibility; Obstruction of Flow; Patient-Device Incompatibility
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2023, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ANEURYSM USING THE GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS AND 3 GORE® EXCLUDER® AAA ENDOPROSTHESIS. ON (B)(6) 2024, THE PATIENT HAD THROMBUS. BOTH OF THEIR EXTERNAL ILIACS THROMBOSED AND A CLOT WENT NORTH. THEIR SYSTEM WAS OCCLUDED. THE PHYSICIAN HAS NOT RE-INTERVENED; HOWEVER, THEY ARE PLANNING NEXT STEPS. THEY WILL POSSIBLY PERFORM AN AXILLA-FEMORAL BYPASS. AS OF NOW, THE PATIENT IS STABLE. THE PHYSICIAN SUSPECTED THAT THE PATIENT HAD A CLOTTING DISORDER AND CLOTTED THE LEFT EXTERNAL ILIAC AND IT CONTINUED PROXIMAL INTO THE EXCLUDER.
Patient problems: Obstruction/Occlusion; Thrombosis/Thrombus
MAUDE report 18827184 ↗InjuryJan 17, 2023Partial Blockage; Partial Blockage
THE FOLLOWING WAS REPORTED TO GORE: PATIENT HAD AN OCCLUDED LEFT LIMB. THIS WAS OCCLUDED FROM THE TOP OF THE BIFURCATION TO THE LEFT HYPOGASTRIC ARTERY. THERE WAS A NARROWING IN THE VBX DEVICE WHICH WAS IMPLANTED IN THE LEFT COMMON ILIAC ARTERY (CIA). THE INITIAL IMPLANT ON DEC. 16 WAS WITH A PLL161007 ABOVE THE LCIA AND HAD AN EXTENSION OF A 8L X79. THROMBECTOMY CATHETER WAS USED AND OPENED VESSEL AND THAN WE USED KISSING 8L STENTS JUST ABOVE FLOW DIVIDER TO RESTORE FLOW. PATIENT DOING WELL.
Patient problems: Inflammation; Pain
MAUDE report 16184324 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page